Skin & Cosmetic Limited evidence

SYN-COLL

Palmitoyl tripeptide-5

Also known as: Syn-Coll, Palmitoyl tripeptide-5

In plain language

SYN-COLL is a synthetic peptide used in anti-aging skincare and marketed to support a firmer, smoother look by encouraging collagen-related activity. Some cosmetic studies exist, but much of the data is manufacturer-sponsored, so independent human evidence is limited.

What it is explored for

SYN-COLL is a popular collagen-focused peptide in firming skincare, and its appeal makes sense for anyone interested in long-term skin support. Small, mostly manufacturer-linked studies report a firmer, smoother look with regular use, so while the independent evidence stays limited, it remains a gentle ingredient that is rewarding to explore over time.

  • Skin firmness and a more supported look
  • Smoother-looking fine lines
  • Support for the skin's natural collagen-related activity
  • Overall skin texture and resilience
  • Daily anti-aging serums and moisturizers

These are areas of active interest and reported use, not proven outcomes. This peptide carries a limited evidence rating, see the evidence summary below for how strong the science actually is.

How it works

SYN-COLL is a palmitoylated tripeptide marketed to support collagen production. The rationale draws on a peptide sequence said to mimic a natural activator of skin matrix activity.

  • Collagen signaling. It is marketed as mimicking thrombospondin-derived signaling associated with activating TGF-beta and stimulating collagen production.
  • Lipid conjugation. The palmitoyl group is added to improve fat solubility and help the peptide cross the skin barrier.
  • Surface conditioning. As with many serums, part of the perceived firmness may reflect hydration and film-forming effects of the formulation.

The collagen-signaling mechanism is supported mainly by in-vitro work and manufacturer rationale rather than robust human data.

Evidence summary

A small number of mostly manufacturer-linked studies report modest improvements in the appearance of wrinkles and firmness. The data is limited in scale and not independently replicated, so the evidence is limited.

Reported safety & side effects

SYN-COLL is generally considered well tolerated in leave-on cosmetics at typical use levels, with a low reported rate of irritation. Independent long-term safety data are limited.

Typical reactionsGenerally well tolerated; irritation uncommon
Use contextTopical leave-on cosmetics (creams
Human safety dataLimited independent data; not an approved drug

Frequently asked

What is SYN-COLL marketed to do?

It is marketed to support the appearance of firmer, smoother skin by encouraging collagen-related activity in the skin matrix.

Is the collagen effect proven in people?

Not robustly. Most support comes from in-vitro work and manufacturer studies, so the effect in living human skin is limited rather than well established.